The Biden administration has gone all in on the COVID-19 antiviral Paxlovid, announcing new measures to make the oral treatment more widely available and making it clear that Vice President Harris used it as she recovered from the coronavirus.
The White House has said it will nearly double the amount of Paxlovid available around the country and that it is working to set up more Test-to-Treat locations in pharmacies and other locations.
But the administration faces a number of obstacles in really making Paxlovid, and a similar treatment from Merck and Ridgeback known as molnupiravir, easily accessible to Americans.
Vinay Prasad, a top vaccine regulator ousted from the Food and Drug Administration (FDA) late last...
A federal judge blocked enforcement of a provision in President Donald Trump's recently enacted tax and...
Health Secretary Robert F. Kennedy Jr. signed a controversial recommendation July 23 from a vaccine panel...
